# Final MLP Model Summary - Complete Optimization Journey

**Author**: Francisco (Team Member 3)  
**Date**: December 2024

---

## Executive Summary

This document summarizes the complete optimization journey from baseline MLP to the final optimized model for diabetes prediction. The final model achieves **83.56% recall** with **1,162 false negatives**, making it suitable for healthcare screening applications.

---

## Optimization Journey Overview

### Stage 1: Baseline MLP
- **Architecture**: [128, 64, 32] with 0.3 dropout
- **Hyperparameters**: LR=0.001, Batch=256, Adam
- **Performance**: 75.84% recall, 1,708 false negatives

### Stage 2: Architecture Tuning
- **Best Architecture**: A5_HighDropout [128, 64] with 0.5 dropout
- **Performance**: 80.10% recall, 1,407 false negatives
- **Improvement**: +4.26% recall, -301 false negatives

### Stage 3: Hyperparameter Optimization
- **Best Configuration**: LR=0.0001, Batch=128, Adam
- **Performance**: 83.56% recall, 1,162 false negatives
- **Improvement**: +3.46% recall, -245 false negatives

---

## Final Model Configuration

### Architecture
- **Hidden Layers**: [128, 64]
- **Dropout Rate**: 0.5
- **Total Parameters**: 11,905
- **Description**: A5_HighDropout - Higher dropout for regularization

### Hyperparameters
- **Learning Rate**: 0.0001
- **Batch Size**: 128
- **Optimizer**: Adam
- **Epochs**: Variable (early stopping enabled)
- **Class Imbalance Handling**: SMOTE

### Threshold
- **Optimal Threshold**: 0.44 (from threshold tuning)
- **Default Threshold**: 0.5 (for comparison)

---

## Performance Comparison

### At Optimal Threshold (0.44)

| Model Stage | Recall | F2-Score | ROC-AUC | False Negatives | Improvement |
|------------|--------|----------|---------|-----------------|-------------|
| **Baseline MLP** | 75.84% | 0.5924 | 0.8227 | 1,708 | - |
| **Best Architecture** | 80.10% | 0.5981 | 0.8202 | 1,407 | +4.26% recall |
| **Final Optimized** | **83.56%** | **0.6017** | **0.8227** | **1,162** | **+3.46% recall** |

### Cumulative Improvement

- **Total Recall Improvement**: +7.72 percentage points (75.84% → 83.56%)
- **Total False Negatives Reduced**: 546 cases (1,708 → 1,162)
- **Relative Reduction**: 32.0% fewer missed diabetes cases

---

## Detailed Metrics - Final Model

### At Optimal Threshold (0.44) - Primary Metrics

- **Accuracy**: 68.34%
- **Precision**: 28.39%
- **Recall**: **83.56%** ⭐
- **F1-Score**: 0.4238
- **F2-Score**: **0.6017** ⭐
- **ROC-AUC**: **0.8227** ⭐
- **False Negatives**: **1,162** ⭐

### At Default Threshold (0.5) - Comparison

- **Accuracy**: 72.56%
- **Precision**: 30.88%
- **Recall**: 78.30%
- **F1-Score**: 0.4429
- **F2-Score**: ~0.599
- **ROC-AUC**: 0.8227
- **False Negatives**: ~1,538

---

## Healthcare Impact Analysis

### Final Model Performance

**Recall (83.56%)**:
- ✅ **Excellent recall (≥80%)** - Exceeds healthcare screening target
- 83.56% of actual diabetes cases are correctly identified
- Only 16.44% of diabetes cases are missed

**False Negatives (1,162)**:
- ✅ **Significantly reduced** from baseline (1,708 → 1,162)
- **546 fewer missed cases** compared to baseline
- **32.0% reduction** in false negatives

**Trade-off Analysis**:
- Precision (29.71%) is lower but acceptable for screening
- False positives lead to follow-up tests (acceptable cost)
- False negatives lead to missed diagnoses (unacceptable)
- ✅ **Optimal balance for healthcare screening**

### Comparison with Baseline

| Metric | Baseline | Final Model | Improvement |
|--------|----------|-------------|-------------|
| **Recall** | 75.84% | **83.56%** | **+7.72%** ⭐ |
| **False Negatives** | 1,708 | **1,162** | **-546 cases** ⭐ |
| **F2-Score** | 0.5924 | **0.6017** | **+0.0093** |
| **ROC-AUC** | 0.8227 | **0.8227** | Stable |

---

## Optimization Insights

### Architecture Tuning Findings

1. **Higher Dropout (0.5) Better**: Regularization helped prevent overfitting
2. **Simpler Architecture**: [128, 64] outperformed deeper/wider networks
3. **Key Insight**: Moderate complexity with strong regularization works best

### Hyperparameter Optimization Findings

1. **Lower Learning Rate (0.0001) Better**: More stable training, better convergence
2. **Smaller Batch Size (128) Better**: Better gradient estimates, improved generalization
3. **Adam Optimizer**: Consistent performance across configurations
4. **Key Insight**: Slower, more careful training improves recall

### Threshold Tuning Impact

- **Optimal Threshold (0.44)**: Prioritizes recall over precision
- **Impact**: +4.92% recall improvement over default (0.5)
- **Healthcare Justification**: Catching more cases is critical

---

## Model Selection Rationale

### Why This Configuration?

1. **Highest Recall**: 83.60% exceeds 80% target for healthcare
2. **Lowest False Negatives**: 1,159 is the best achieved
3. **Good F2-Score**: 0.6032 balances recall and precision
4. **Stable ROC-AUC**: 0.8225 indicates good discriminative ability
5. **Healthcare Appropriate**: Prioritizes catching cases over precision

### Trade-offs Accepted

- ✅ **Lower Precision (29.71%)**: Acceptable for screening (false positives are manageable)
- ✅ **Lower Accuracy (70.82%)**: Acceptable given class imbalance focus
- ✅ **More False Positives**: Leads to follow-up tests but prevents missed diagnoses

---

## Final Model Files

### Saved Artifacts

1. **Model**: `models/francisco_mlp_final_optimized.h5`
2. **Predictions**: `models/francisco_mlp_final_predictions.csv`
3. **Metrics**: `models/francisco_mlp_final_metrics.csv`

### Visualizations

1. **ROC Curve**: `figures/francisco_mlp_final_roc_curve.png`
2. **PR Curve**: `figures/francisco_mlp_final_pr_curve.png`
3. **Confusion Matrix**: `figures/francisco_mlp_final_confusion_matrix.png`
4. **Training Curves**: `figures/francisco_mlp_final_training_curves.png`

---

## Recommendations

### For Report Writing

1. **Use Final Model Metrics**: All metrics at optimal threshold (0.44)
2. **Highlight Improvements**: Show progression from baseline → architecture → hyperparameters
3. **Emphasize Healthcare Impact**: 549 fewer missed cases is significant
4. **Explain Trade-offs**: Lower precision is acceptable for higher recall

### For Presentation

1. **Start with Baseline**: Show initial performance
2. **Show Architecture Improvement**: +4.26% recall improvement
3. **Show Hyperparameter Improvement**: +3.50% additional recall
4. **End with Final Model**: 83.60% recall, suitable for screening

### For Deployment

1. **Use Optimal Threshold (0.44)**: Maximizes recall for healthcare
2. **Monitor False Negatives**: Track missed cases in production
3. **Follow-up Protocol**: False positives should trigger confirmatory tests
4. **Regular Re-evaluation**: Re-tune as data distribution changes

---

## Conclusion

The final optimized MLP model achieves **83.56% recall** with **1,162 false negatives**, representing a **32.0% reduction** in missed diabetes cases compared to the baseline. This performance makes the model suitable for healthcare screening applications where catching diabetes cases is critical.

**Key Achievements**:
- ✅ Exceeded 80% recall target
- ✅ Reduced false negatives by 549 cases
- ✅ Maintained good ROC-AUC (0.8225)
- ✅ Optimized for healthcare screening context

**Status**: ✅ **Ready for report and presentation**

---

## Next Steps

1. ✅ Final model trained and evaluated
2. ✅ All visualizations generated
3. ⏭️ Compare with teammates' models (Logistic Regression, Random Forest, Gradient Boosting)
4. ⏭️ Write Deep Learning section of report
5. ⏭️ Prepare presentation materials

